Stage I Grade 3 Follicular Lymphoma Completed Phase 2 Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0029477 (Stage I Grade 3 Follicular Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01789255Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesSupportive Care
NCT00489203Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerSupportive Care